A new drug compound could combat tough-to-treat melanoma
Melanoma is commonly caused by the damaging effects of ultraviolet light—from sources like sunlight and tanning beds—on the DNA of skin cells. This UV damage can activate genes that encourage precancerous cells to further mutate into full-blown skin cancer. At the same time, UV damage can turn off other genes that would normally prevent tumor growth. With enough wrongly flipped switches, cancer can flourish. And melanoma is certainly flourishing. This year alone, 96,480 new instances of melanoma will be diagnosed in the United States and 7,230 Americans will die from the disease.
With so many people affected by melanoma, scientists are on the hunt for better ways to screen for melanoma risk and treat the most lethal types of skin cancer. One particularly voracious type of melanoma, caused by mutation of a gene called NRAS (which instructs cells to produce a protein of the same name, NRAS), drives 25 percent of skin cancers.
“There are immunotherapies and targeted therapies that have shown huge improvements for patients with melanoma,” said Rutao Cui, a Boston University School of Medicine professor of pharmacology and dermatology. “However, for patients with NRAS mutations, they don’t have very useful or very effective treatment strategies.”
Now, an international research team led by Cui has discovered a new way to stop the progression of melanoma by NRAS mutations with the flip of a genetic switch. Their findings were published January 31, 2019, in Cell.
Inside our bodies, proteins like NRAS play the role of dominoes, interacting with one another to switch other important gene activities on or off. The researchers set out in search of a way to interrupt the process in which mutated NRAS can instigate the growth of skin cancer. Since targeting the NRAS gene—just one of several dominoes in this type of skin cancer pathway—has proven to be so difficult, the researchers were determined to find another approach.
For NRAS to trigger cancer development, it first needs to be activated by another protein in the body. Until now, it’s been unknown exactly which protein is responsible for activating NRAS. But after testing the effect of several different proteins on the activity of NRAS, the team zeroed in on a likely culprit, a protein by the name of STK19.
STK19 is not a newly discovered protein in its own right, but its purpose has not been known until now. Cui’s team found that STK19 appears to work as an “on” switch for NRAS—activating production of NRAS proteins which, in turn, trigger the toppling of several other genetic dominoes downstream.
The researchers also found that, unlike NRAS, they could disable the STK19 gene and greatly diminish its ability to set the skin cancer sequence in motion.
Together, the team designed a new drug compound to shut down the effect of STK19 on NRAS. Then, testing its effect on skin cells cultured in petri dishes and in animal models, they proved that their compound can block NRAS activation and prevent melanoma from developing.
Cui says that this result is exciting not just for melanoma, but for other cancers as well. While the relationship between STK19 and NRAS may be particular to skin cancer, the approaches the team used to identify and block key activating proteins can be applied to find new treatments for similarly difficult-to-cure cancers.
Now the research team is looking to take their research to clinical trials to test out the STK19 inhibitor in humans, and hopefully, someday make it available as a targeted therapy to combat NRAS-driven melanomas.
In the meantime, Cui says that much work still needs to be done to not only create better and more precise treatments for patients suffering with melanoma, but also to alert vulnerable populations about the risk factors associated with the cancer.
“We need more monitoring for early diagnosis and full-body examinations for problematic spots,” says Cui, “and more proactive strategies for patients [at the highest risk of developing melanoma] to prevent cancer progression and metastasis.”
Learn more: Shutting Down Skin Cancer
The Latest on: Skin cancer
via Google News
The Latest on: Skin cancer
- If You Can Spot It, You Can Stop It: Schedule an Annual Skin Exam With Your Dermatologiston May 3, 2021 at 5:53 am
When caught and treated early, skin cancer is highly curable. When allowed to progress, however, it can cause disfigurement and even death.
- Advanced Dermatology and Cosmetic Surgery and SciBase team up to raise awareness of skin canceron May 3, 2021 at 5:38 am
SciBase Holding AB ("SciBase") (STO:SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today, on "Melanoma Monday", their joint efforts with Advanced ...
- Mum diagnosed with skin cancer after using sun beds for just three months as she was tired of fake tanon May 3, 2021 at 4:41 am
Warning: Graphic images - Lucy Hartland is sharing her story to urge others to embrace fake tan after recovering from stage 1A melanoma ...
- Everything you need to know about Melanoma and protecting yourself from skin canceron May 3, 2021 at 3:49 am
May is Skin Cancer Awareness Month and today is Melanoma Monday, a day focused on raising awareness of the deadliest form of skin cancer. Melanoma Monday in the first Monday in May. Black color ribbon ...
- Cutting-edge detection tech hoped-for ‘breakthrough’ for NY doctor who’s waged a lifelong battle with skin cancerson May 2, 2021 at 6:15 am
For over a year as the COVID-19 pandemic raged, the 84-year-old former cardiologist, who lamented he “can’t open the blinds without getting cancer,” hasn’t been able to have a skin check, and waited ...
- Take steps to protect yourself from skin cancer [column]on May 2, 2021 at 2:00 am
The start of spring means more time spent outside and increased potential exposure to the sun’s harmful UV rays. Skin cancer is the most common type of cancer in America.
- Skin cancer diagnosis is about to undergo a revolutionon May 2, 2021 at 12:24 am
Patternox is developing an optical scanner to detect suspicious light patterns in lesions long before changes can be seen on the skin’s surface.
- Diagnosed at 24, young skin-cancer survivor has a message for Minnesotans ahead of summeron May 1, 2021 at 5:33 pm
Taylor Runkel, left, was diagnosed with skin cancer at age 24. She says she wishes she had taken better care of her skin growing up and avoided tanning beds. A week or so later, she had surgery to ...
- Skin Cancer Awareness Month: What You Need to Know to Protect Yourself All Year Longon April 30, 2021 at 5:03 pm
Melanoma, commonly referred to as skin cancer, is the deadliest form of cancer, but it's also the most preventable. Neutrogena is the leader in the sun protection category, not only offering a wide ...
- Op-ed: Colorado is famous for blue sky, sunshine…and skin canceron April 30, 2021 at 12:30 pm
With 300 days of sunshine and plenty of outdoor activities across Colorado, it's important for one to take care of their skin and keep it protected.
via Bing News